Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2016 Mar;16(3):212-3.
doi: 10.14744/AnatolJCardiol.2016.6813.

Inappropriate sinus tachycardia-induced cardiomyopathy during pregnancy and successful treatment with ivabradine

Saim Sağ  1 , Hakan Çoşkun  2 , İbrahim Baran  2 , Sümeyye Güllülü  2 , Ali Aydınlar  2
Affiliations
Case Reports

Inappropriate sinus tachycardia-induced cardiomyopathy during pregnancy and successful treatment with ivabradine

Saim Sağ et al. Anatol J Cardiol. 2016 Mar.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
The electrocardiogram (ECG) taken at the time of admission showed that the patient had sinus tachycardia with a heart rate of 152 bpm (a). Following a maximum treatment regimen (200 mg/day of metoprolol, 0.25 mg/day of digoxin, and 240 mg/day of verapamil), the ECG showed sinus tachycardia with the heart rate of 120 bpm (b). After ivabradine treatment, the ECG showed sinus rhythm with the heart rate reduced to 90 bpm (c), and the ECG at discharge showed sinus rhythm within the normal range (d)
Figure 2
Figure 2
Prior to starting treatment with ivabradine, fetal echocardio-graphy showed a heart rate of 156 bpm (a). On the 1st day of ivabradine treatment, the fetal ECG showed that the fetal heart rate was 150 bpm (b). On the 1st week of ivabradine treatment, the fetal heart rate reduced to 148 bpm (c). After delivery, the mother continued her ivabradine treatment, and the ECG of the baby, who was fed only breast milk, showed sinus rhythm with a heart rate of 180 bpm (d)
See this image and copyright information in PMC

References

    1. Szumowski L, Szufladowicz E, Orczykowski M, Bodalski R, Derejko P, Przybylski A, et al. Ablation of severe drug-resistant tachy-arrhythmia during pregnancy. J Cardiovasc Electrophysiol. 2010;21:877–82. - PubMed
    1. Gianni C, Di Biase L, Mohanty S, Gökoğlan Y, Güneş MF, Horton R, et al. Catheter ablation of inappropriate sinus tachycardia. J Interv Card Electrophysiol. 2015 Aug 27; Epub ahead of print. - PubMed
    1. Salazar Adum JP, Arora R. Treatment for inappropriate sinus tachycardia. Am J Ther. 2015 Sep 16; Epub ahead of print. - PubMed
    1. Fox K, Ford I, Steg PG, Tendera M, Ferrari R. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL):a randomized, double- blind, placebo-controlled trial. Lancet. 2008;372:807–16. - PubMed
    1. Mason PK, Di Marco JP. New pharmacological agents for arrhythmias. Circ Arrhythm Electrophysiol. 2009;2:588–97. - PubMed

Publication types

MeSH terms